
|Podcasts|August 26, 2022
Pharmacy Focus: Psychedelic Pharmacy - The Future of Ketamine
Industry partnerships will be essential to improving access to ketamine, according to expert Kevin Nicholson.
Advertisement
This month, we spoke with Kevin Nicholson, CEO of Ketamine Wellness Centers and recently-announced CEO of Delic Corp., to discuss the future of ketamine research and why industry partnerships will be crucial to improving access.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
2
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
3
FDA Approves Lumateperone With Antidepressant Use for Major Depressive Disorder
4
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
5













































































































































































































